Medicinal compositions containing HMG-CoA reductase inhibitor and ACAT inhibitor

摘要

A pharmaceutical composition for treating or preventing of xanthoma and atherosclerosis comprising as active ingredients: a) an ACAT inhibitor, N-(1-octyl-5-carboxymethyl-4,6-dimethylindolin-7-yl)-2,2-dimethylpropanamide; b) HMG-CoA reductase inhibitor (such as pravastatin, lovastatin, simvastatin and atorvastatin for example)